336 related articles for article (PubMed ID: 30135245)
1. Advances in Engineered Human Liver Platforms for Drug Metabolism Studies.
Underhill GH; Khetani SR
Drug Metab Dispos; 2018 Nov; 46(11):1626-1637. PubMed ID: 30135245
[TBL] [Abstract][Full Text] [Related]
2. Micropatterned Co-Cultures of Human Hepatocytes and Stromal Cells for the Assessment of Drug Clearance and Drug-Drug Interactions.
Lin C; Khetani SR
Curr Protoc Toxicol; 2017 May; 72():14.17.1-14.17.23. PubMed ID: 28463419
[TBL] [Abstract][Full Text] [Related]
3. Emerging trends in modeling human liver disease
Underhill GH; Khetani SR
APL Bioeng; 2019 Dec; 3(4):040902. PubMed ID: 31893256
[TBL] [Abstract][Full Text] [Related]
4. Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists.
Hutzler JM; Ring BJ; Anderson SR
Drug Metab Dispos; 2015 Dec; 43(12):1917-28. PubMed ID: 26363026
[TBL] [Abstract][Full Text] [Related]
5. Human hepatic cell cultures: in vitro and in vivo drug metabolism.
Gómez-Lechón MJ; Donato T; Ponsoda X; Castell JV
Altern Lab Anim; 2003; 31(3):257-65. PubMed ID: 15612868
[TBL] [Abstract][Full Text] [Related]
6. A Novel In Vitro Experimental System for the Evaluation of Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Cryopreserved Human Hepatocytes).
Li AP; Ho MD; Amaral K; Loretz C
Drug Metab Dispos; 2018 Nov; 46(11):1608-1616. PubMed ID: 29363498
[TBL] [Abstract][Full Text] [Related]
7. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.
Sahi J; Grepper S; Smith C
Curr Drug Discov Technol; 2010 Sep; 7(3):188-98. PubMed ID: 20843293
[TBL] [Abstract][Full Text] [Related]
8. Physiologically inspired culture medium prolongs the lifetime and insulin sensitivity of human hepatocytes in micropatterned co-cultures.
Davidson MD; Pickrell J; Khetani SR
Toxicology; 2021 Feb; 449():152662. PubMed ID: 33359713
[TBL] [Abstract][Full Text] [Related]
9. Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells.
Baze A; Parmentier C; Hendriks DFG; Hurrell T; Heyd B; Bachellier P; Schuster C; Ingelman-Sundberg M; Richert L
Tissue Eng Part C Methods; 2018 Sep; 24(9):534-545. PubMed ID: 30101670
[TBL] [Abstract][Full Text] [Related]
10. Liver microphysiological platforms for drug metabolism applications.
Kulsharova G; Kurmangaliyeva A
Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
[TBL] [Abstract][Full Text] [Related]
11. Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development.
Davidson MD; Kukla DA; Khetani SR
Integr Biol (Camb); 2017 Aug; 9(8):662-677. PubMed ID: 28702667
[TBL] [Abstract][Full Text] [Related]
12. Micropatterned Coculture With 3T3-J2 Fibroblasts Enhances Hepatic Functions and Drug Screening Utility of HepaRG Cells.
Ware BR; Liu JS; Monckton CP; Ballinger KR; Khetani SR
Toxicol Sci; 2021 Apr; 181(1):90-104. PubMed ID: 33590212
[TBL] [Abstract][Full Text] [Related]
13. Intermittent Starvation Extends the Functional Lifetime of Primary Human Hepatocyte Cultures.
Davidson MD; Khetani SR
Toxicol Sci; 2020 Apr; 174(2):266-277. PubMed ID: 31977024
[TBL] [Abstract][Full Text] [Related]
14. Latest impact of engineered human liver platforms on drug development.
Monckton CP; Brown GE; Khetani SR
APL Bioeng; 2021 Sep; 5(3):031506. PubMed ID: 34286173
[TBL] [Abstract][Full Text] [Related]
15. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
[TBL] [Abstract][Full Text] [Related]
16. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Assessment In Vitro of Transporter and Metabolic Processes in Hepatic Drug Clearance: Use of a Media Loss Approach.
Harrison J; De Bruyn T; Darwich AS; Houston JB
Drug Metab Dispos; 2018 Apr; 46(4):405-414. PubMed ID: 29439129
[TBL] [Abstract][Full Text] [Related]
18. Human hepatocytes as a tool for studying toxicity and drug metabolism.
Gómez-Lechón MJ; Donato MT; Castell JV; Jover R
Curr Drug Metab; 2003 Aug; 4(4):292-312. PubMed ID: 12871046
[TBL] [Abstract][Full Text] [Related]
19. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
20. The application of engineered liver tissues for novel drug discovery.
Lin C; Ballinger KR; Khetani SR
Expert Opin Drug Discov; 2015 May; 10(5):519-40. PubMed ID: 25840592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
